TRDX's New Pharmaceutical Distribution Division Books Revenue From Earlier Than Expected Sales

   SciMeDent Health, Corp. f/k/a Trend Exploration, Inc. (PINKSHEETS: TRDX) is pleased to announce that Preferred Distribution, Inc. ("Preferred"), its medical/dental supply distribution subsidiary, has received payment from its recently generated purchase orders from its new pharmaceutical distribution division. These booked sales have generated revenue on an earlier than expected timeframe.

Dr. Jan Stahl, CEO of TRDX, stated, "We are pleased with the initial sales for our new pharmaceutical division. We look forward to our official launch of this new division in the second quarter and further growth in Preferred's revenue."

The pharmaceutical wholesale sector is one of the fastest sales generators in the world. IMS Health reported that the size of the global market for pharmaceuticals is expected to grow nearly $300 billion over the next five years, reaching $1.1 trillion in 2014.

About SciMeDent f/k/a Trend Exploration, Inc. (PINKSHEETS: TRDX)

SciMeDent (www.scimedenthealth.com) is a company focused on being a leading developer and marketer of products and services for medicine, dentistry and life sciences. SciMeDent plans to achieve growth initially through mergers and acquisitions.

About Preferred Distribution, Inc.

Preferred Distribution, Inc. is a wholly owned subsidiary of SciMeDent. Preferred's goal is to supply the medical, dental and veterinary community with quality products at the lowest possible prices. Preferred prides itself on providing professional sales staff who are courteous, knowledgeable and dedicated to saving you time and money for your practice. Since 1987 Preferred has been serving the needs of professionals throughout the country. Preferred's dental products division is marketed through its website, www.preferreddist.com.

Cautionary Statement Regarding Forward-Looking Statements

A number of statements contained in this press release are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, including the sufficiency of existing capital resources, technological or industry changes and uncertainties related to the development of the Company's business model. The actual results the Company may achieve could differ materially from any forward-looking statements due to such risks and uncertainties.

Contact: Cadence Consulting, LLC. Dan Myers 1-866-383-1374 [e-mail]